首页 › 基金 › Lynx1 Capital Management LP › CGEM
Lynx1 Capital Management LP 对 CGEM 的持仓历史
CULLINAN THERAPEUTICS INC · 医疗保健
Lynx1 Capital Management LP 在 Q3 2026 的 13F 申报中披露持有 CGEM(CULLINAN THERAPEUTICS INC)8,963,500 股,市值约 US$137.6M,约占其申报组合的 21.30%,在其申报持仓中市值排名第 2 位。 Lynx1 Capital Management LP 最近 10 个申报季度中有 10 个季度披露了 CGEM 持仓,最早可追溯至 Q2 2024。
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
Lynx1 Capital Management LP 对 CGEM 的持仓演变
Lynx1 Capital Management LP 于 Q2 2024 首次披露 CGEM 持仓:377,323 股(约 US$6.6M)。 该持仓在 Q2 2026 达到峰值 8,963,500 股,市值约 US$163.2M。 在 10 次申报中,Lynx1 Capital Management LP 6 次增持、0 次减持、3 次保持不变。 最近一期申报(Q3 2026)显示持股 8,963,500 股、市值约 US$137.6M。 持仓曾出现大幅变动:Q4 2024 增持约 206% (随后一个季度股价下跌 38%)、Q1 2025 增持约 156% (随后一个季度股价基本持平)、Q4 2025 增持约 55% (随后一个季度股价上涨 37%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2024 | 377.32K | $6.58M | 新进 |
| Q3 2024 | 410.83K | $6.88M | 增持 |
| Q4 2024 | 1.26M | $15.32M | 增持 |
| Q1 2025 | 3.22M | $24.34M | 增持 |
| Q2 2025 | 4.40M | $33.14M | 增持 |
| Q3 2025 | 5.77M | $34.19M | 增持 |
| Q4 2025 | 8.96M | $92.77M | 增持 |
| Q1 2026 | 8.96M | $127.37M | 持有 |
| Q2 2026 | 8.96M | $163.23M | 持有 |
| Q3 2026 | 8.96M | $137.59M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 CGEM 与 13F 数据
CGEM(CULLINAN THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 31 只申报持有 CGEM,申报仓位最大的包括:MPM BioImpact LLC (US$149.2M), BVF INC/IL (US$88.3M), Kynam Capital Management, LP (US$47.8M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 CGEM 的基金
- MPM BioImpact LLC 9.72M 股 · $149.22M · Q3 2026
- BVF INC/IL 5.75M 股 · $88.27M · Q3 2026
- Kynam Capital Management, LP 3.11M 股 · $47.80M · Q3 2026
- RTW INVESTMENTS, LP 2.36M 股 · $36.29M · Q3 2026
- Siren, L.L.C. 1.79M 股 · $27.53M · Q3 2026
- Blue Owl Capital Holdings LP 1.40M 股 · $21.49M · Q3 2026
- Venrock Adviser, LLC 1.38M 股 · $21.18M · Q3 2026
- Elmind Capital, LP 962.79K 股 · $14.78M · Q3 2026
- Affinity Asset Advisors, LLC 875.76K 股 · $13.44M · Q3 2026
- BOONE CAPITAL MANAGEMENT LLC 690.81K 股 · $10.60M · Q3 2026
- TWIN FOCUS CAPITAL PARTNERS, LLC 595.49K 股 · $9.14M · Q3 2026
- Boxer Capital Management, LLC 450.00K 股 · $6.91M · Q3 2026
更多关于 Lynx1 Capital Management LP
常见问题
How long has Lynx1 Capital Management LP held CGEM?
Lynx1 Capital Management LP has disclosed CGEM holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
What is Lynx1 Capital Management LP's current position in CGEM?
As of Q3 2026, Lynx1 Capital Management LP holds 8.96M shares of CGEM (CULLINAN THERAPEUTICS INC), valued at $137.59M, representing 21.30% of its reported portfolio and ranking #2.
Has Lynx1 Capital Management LP been buying or selling CGEM?
In the latest 13F filing (Q3 2026), Lynx1 Capital Management LP held unchanged its position in CGEM. The position peaked in Q2 2026 at 8.96M shares.
Which other funds hold CGEM?
Other major institutional holders of CGEM include MPM BioImpact LLC, BVF INC/IL, Kynam Capital Management, LP, among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.